Here's Why Sarepta Therapeutics Shares Rocketed 17.8% In January
The company rewarded investors with some good news last month.
Summit Therapeutics
SMMT
SMMT
$1.54
-$0.02
-1.0%
BATS BZX Real Time Price as of November 20, 2019, 4:00 p.m. EST
View Interactive SMMT Charts
News & Analysis: Summit Therapeutics
Why Summit Therapeutics Shares Climbed 12.9% Today
Could the company's lead drug candidate eventually become standard care in Duchenne muscular dystrophy?
